Browse the evidence

Small nucleolar size is a conserved cellular hallmark of longevity and metabolic health across multiple species, including C. elegans, Drosophila, mice, and humans.

This research identifies small nucleoli as a marker of longevity and metabolic health. While you cannot directly 'exercise' your nucleoli, interventions that promote longevity—such as dietary restriction and exercise—are associated with this cellular feature. For humans, combining modest caloric restriction with increased physical activity was linked to smaller nucleoli in muscle biopsies, suggesting this cellular change is a reversible marker of metabolic improvement.

In patients with cirrhosis, sarcopenia is driven by a multifactorial imbalance between protein synthesis and breakdown, specifically involving hyperammonemia, increased autophagy, and impaired mitochondrial function, rather than just caloric deficit.

For cirrhosis patients, muscle loss is a complex biological failure, not just a diet problem. Treatment requires addressing the root causes like ammonia levels and inflammation, not just increasing calories.

Higher intake of alcohol (per 10 g/day increment) is associated with an 8% higher risk of colorectal cancer, independent of meat and fiber intake.

Increasing alcohol intake is linked to a higher risk of colorectal cancer. For every 10 grams of alcohol consumed per day, risk increases by 8%. Reducing alcohol intake can help lower this risk.

Fish, poultry, cheese, tea, and coffee consumption are not associated with colorectal cancer risk in this study.

You do not need to avoid fish, poultry, cheese, tea, or coffee due to colorectal cancer risk, as this study found no association.

Genetic variants associated with obesity (such as FTO) explain less than 3% of BMI variation, failing to account for the 47-80% heritability estimates or the rapid global rise in obesity prevalence.

Do not blame your genetics for obesity. Current science shows that known genetic markers account for less than 3% of body weight variation. The rapid global increase in obesity is driven by environmental and lifestyle factors, not a sudden change in human DNA. This means your daily choices regarding diet and activity have a disproportionately large impact on your weight compared to your genetic predisposition.

Caloric restriction (30-40%) delays age-related DNA methylation drift, resulting in a significantly younger biological (methylation) age compared to chronological age in mice and rhesus monkeys.

In animal models, sustained caloric restriction (30-40% reduction) significantly slows the epigenetic aging clock, making biological tissues appear years younger than their chronological age. This suggests that managing energy intake may be a potent lever for delaying molecular aging processes in mammals.

Low socioeconomic status (SES) is associated with accelerated epigenetic aging, specifically an increase in biological age of approximately 1 year compared to high SES, independent of major lifestyle risk factors.

Social environment impacts biological aging. While you cannot change your past, improving your social and economic conditions, especially in early life, may help slow down biological aging processes. Focus on reducing chronic stress and building supportive social networks as these are key components of socioeconomic well-being.

Aging is associated with a decline in skeletal muscle mitochondrial capacity, exercise efficiency, and insulin sensitivity, even when habitual physical activity levels are comparable to young adults.

Aging naturally reduces muscle mitochondrial capacity and insulin sensitivity, even if you stay active. This decline contributes to reduced exercise efficiency and physical function, highlighting the importance of targeted exercise training to mitigate these age-related changes.

Mitochondrial dysfunction acts as a primary driver of skeletal muscle atrophy by triggering catabolic signaling pathways that promote the expression of muscle atrophy genes and increasing oxidative stress.

To support muscle mass, prioritize activities that improve mitochondrial health, such as regular aerobic and resistance exercise. These interventions help regulate mitochondrial function and may prevent or treat muscle atrophy, especially in aging or diseased states.

Dietary capsaicin supplementation prevents high-fat diet-induced obesity and chronic low-grade inflammation by modulating gut microbiota to increase butyrate-producing bacteria and decrease lipopolysaccharide-producing bacteria, thereby strengthening the gut barrier and reducing metabolic endotoxemia.

Incorporating capsaicin (found in chili peppers) into a high-fat diet can help mitigate weight gain and inflammation by improving gut health. The mechanism involves increasing beneficial bacteria that produce butyrate and reducing harmful bacteria that trigger inflammation. While this is proven in mice, it suggests that chili consumption may be a useful dietary strategy to support metabolic health, particularly when consuming higher-fat meals.

Being a definite evening chronotype is associated with a significantly increased risk of all-cause mortality compared to being a definite morning type, even after adjusting for age, sex, BMI, smoking, and comorbidities.

If you are a definite evening type, be aware that your natural schedule may carry a slightly higher mortality risk, largely due to misalignment with societal norms. You can mitigate this by prioritizing morning light exposure, avoiding late-night artificial light, and ensuring your diet and sleep habits are optimized. Consider advocating for flexible work hours if possible.

Higher baseline circulating levels of the gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) are independently associated with a significantly increased risk of subsequent cardiovascular events (CVEs) and all-cause mortality.

High blood levels of TMAO are a strong warning sign for future heart problems and death, especially in people with existing heart or kidney disease. While you cannot directly 'dose' TMAO, you can influence it through diet (red meat/eggs increase it, seafood may not) and kidney health. If you have cardiovascular risk factors, discussing TMAO testing with your doctor might provide additional prognostic information, though it is not yet a standard screening tool for everyone.

Increased intramuscular adipose tissue (myosteatosis) and intramyocellular lipids independently impair skeletal muscle function, force generation, and metabolic health in aging adults, often preceding loss of muscle mass.

For older adults, maintaining muscle mass is important, but ensuring muscle 'quality' (low fat infiltration) is equally critical for mobility and metabolic health. Standard weight or BMI measures may miss 'myosteatosis' (fat inside muscles), which impairs strength and insulin sensitivity. Imaging like ultrasound or MRI can assess this, but currently, functional tests (grip strength, gait speed) are the most accessible proxies for muscle quality in clinical settings.

Phase-locked acoustic stimulation of pink noise during sleep slow oscillation upstates increases slow wave activity (SWA) and spindle density, leading to significant improvement in declarative memory consolidation in healthy older adults.

For healthy older adults experiencing age-related memory decline, using phase-locked acoustic stimulation (pink noise pulses timed to slow wave upstates) during sleep can significantly boost memory consolidation. The protocol involves delivering short bursts of pink noise synchronized with the brain's natural slow oscillations, which has been shown to improve word recall by over 20% compared to no stimulation, without disrupting sleep quality.

Genetic variants associated with excessive daytime sleepiness cluster into two distinct biological subtypes: 'sleep propensity' (linked to higher sleep efficiency and morning chronotype) and 'sleep fragmentation' (linked to lower sleep efficiency and insomnia symptoms).

If you struggle with daytime sleepiness, recognize that your experience may stem from one of two genetic predispositions: high sleep drive (propensity) or poor sleep continuity (fragmentation). Those with high propensity may benefit from circadian alignment (morning light), while those with fragmentation may need to address sleep quality or underlying disorders like apnea, rather than just increasing total sleep time.

Genetic risk for daytime sleepiness shares significant genetic overlap with psychiatric traits (neuroticism, depression, bipolar disorder) and coronary heart disease, independent of BMI.

Daytime sleepiness may be a marker for broader health risks, including heart disease and mental health conditions. Managing sleepiness might also be part of a broader strategy to mitigate these shared genetic risks.

Use of proton pump inhibitors (PPIs) or genetic achlorhydria promotes the progression of alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH) by inducing overgrowth and translocation of intestinal Enterococcus species to the liver.

If you have liver disease (alcoholic or fatty) and take acid-reflux medication like omeprazole, discuss with your doctor whether you still need it. This research shows these drugs can worsen liver damage by allowing harmful gut bacteria to reach the liver. Do not stop medication abruptly without medical advice, but be aware that long-term use may carry liver risks.

In cognitively normal elderly individuals, higher severity of obstructive sleep apnea (OSA) is associated with a faster longitudinal decrease in cerebrospinal fluid amyloid-beta 42 levels, indicating increased brain amyloid burden.

If you are over 55 and have symptoms of sleep apnea (loud snoring, gasping, daytime fatigue), getting diagnosed and treated (e.g., with CPAP) is not just about feeling rested; it may actively slow the buildup of Alzheimer's-related proteins in your brain. Prioritize sleep health as a neuroprotective strategy.

Low socioeconomic position (proxied by low education) is independently associated with accelerated biological aging, as measured by epigenetic clocks (Horvath, Hannum, Levine) and stochastic epigenetic mutations (SEMs), with effect sizes comparable to major lifestyle risk factors like obesity and alcohol intake, though smoking has a stronger impact.

Your socioeconomic background, often measured by education level, has a measurable, independent impact on your biological aging speed, distinct from your daily habits. While you cannot change your past, this biological 'memory' is not entirely fixed; improving social conditions and managing lifestyle factors (especially avoiding smoking, which has the strongest epigenetic impact) can mitigate acceleration. Focus on controllable lifestyle levers, as they significantly influence epigenetic clocks.

Dietary fiber interventions in healthy adults do not consistently produce significant increases in total or individual short-chain fatty acid (SCFA) levels, with outcomes strictly dependent on fiber type, dose, and analytical methodology.

Do not assume that taking a generic fiber supplement will automatically boost your short-chain fatty acids. The effect is highly variable and depends on the specific type of fiber (e.g., inulin vs. resistant starch), the dose, and your individual gut microbiome composition. Focus on diverse fiber sources from whole foods rather than expecting a uniform metabolic boost from supplements.

The analytical method used to measure SCFAs (e.g., GC vs. HPLC) significantly influences the detection of statistically significant changes, with GC-based methods on plasma/serum showing more frequent significant changes than HPLC on feces.

When evaluating fiber studies, check the measurement method. Studies using Gas Chromatography (GC) on blood samples are more likely to report significant SCFA changes than those using HPLC on feces, even if the biological effect is similar. This highlights the difficulty in measuring blood SCFAs due to low concentrations.

There is no significant dose-response relationship between the volume, frequency, duration, or pace of running and reduced mortality risk; higher doses do not yield greater benefits than lower doses.

Do not feel pressured to increase your running volume, frequency, or speed to get more health benefits. If you are already running occasionally, you are likely getting the maximum mortality benefit available from running. Focus on consistency rather than intensity or volume.

In heart failure with reduced ejection fraction (HFrEF), higher adiposity measured by waist-to-height ratio is associated with a significantly higher risk of heart failure hospitalization, and the 'obesity-survival paradox' (where higher BMI appeared protective) is eliminated when adjusting for natriuretic peptides and other prognostic variables.

For patients with heart failure and reduced ejection fraction, relying on BMI to assess risk is misleading. Higher waist-to-height ratio (indicating central adiposity) is linked to a significantly higher risk of hospitalization. The idea that being 'overweight' is protective in heart failure is a statistical artifact; once you account for fluid retention and biomarkers like natriuretic peptides, higher adiposity clearly increases risk. Focus on healthy body composition rather than just scale weight.

BMI is a suboptimal tool for predicting chronic disease risk and diagnosing obesity because it fails to distinguish between fat mass and muscle mass, leading to misclassification of athletes and elderly individuals.

Do not rely on BMI alone to determine your health status, especially if you are an athlete or elderly. BMI cannot distinguish between muscle and fat. Use waist circumference or body composition analysis for a more accurate assessment of obesity and health risk.